Get startedLog in
    Picture of Virpax Pharmaceuticals logo

    VRPX — Virpax Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Virpax Announces Clinical Trial Site In Canada For First In Human Study Of Epoladerm For Pain Associated With Osteoarthritis Of The Knee

    Picture of Virpax Pharmaceuticals logoVirpax Pharmaceuticals
    20/12/2021 13:30
    Dec 20 (Reuters) - Virpax Pharmaceuticals Inc  VRPX.O :
    * VIRPAX ANNOUNCES CLINICAL TRIAL SITE IN CANADA FOR FIRST
IN
HUMAN STUDY OF EPOLADERM™ FOR PAIN ASSOCIATED WITH
OSTEOARTHRITIS OF THE KNEE
    * VIRPAX PHARMACEUTICALS INC - FIRST PATIENT EXPECTED TO BE
ENROLLED BY Q2 OF 2022
    * VIRPAX PHARMACEUTICALS INC - DATA TO SUPPORT REGULATORY
FILINGS
IN UNITED STATES

Source text for Eikon:  ID:nBwbh2zhfa 
Further company coverage:  VRPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Virpax Pharmaceuticals

    See all news